Tier-based treatment for opioid use disorder in the primary care setting.

Background: Two primary care clinics implemented an opioid use disorder (OUD) treatment program that integrates behavioral health counseling with buprenorphine treatment and uses tiers. This project aimed to understand how patients moved through tiers in this program. Method: We purposively sampled 20 patients with at least 10 OUD-related treatment visits; we documented tier changes at all visits between September 1, 2016 and December 31, 2018 using a standard data collection instrument. These data were used to construct run-charts. Results: About 45% of sampled patients had at least one relapse noted and 60% of patients dropped in tier during the study. Reductions in tier often happened when the patient was navigating difficult psychosocial situations in their life, whereas increases in tier often accompanied positive life events. We also found variation in use of the tiers. Discussion: OUD treatment from two clinics by tier illustrates that recovery is an individualized process based on patient need that can fluctuate due to psychosocial triggers and significant life events. Having tiers can guide treatment and provide both clinicians and patients with information about what to expect during treatment while still allowing the flexibility to meet patients where they are. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Associations of retention on buprenorphine for opioid use disorder with patient characteristics and models of care in the primary care setting.

INTRODUCTION: Buprenorphine, a medication for opioid use disorder (OUD), can be administered within primary care; however, little is known about characteristics associated with retention on buprenorphine in these settings. This study examines patient correlates of buprenorphine retention and whether an integrated, interdisciplinary treatment model (buprenorphine and behavioral health) is associated with higher odds of buprenorphine retention than a primarily medication-only treatment model. METHODS: Electronic health record data from adult patients with an OUD, ≥1 buprenorphine order and ≥1 visit to either of two primary care clinics between 9/2/2014-6/27/2018 were extracted (N = 494 patients). Two research team members reviewed the medication start and stop dates for each buprenorphine order and classified as retained (≥6 months of orders) or not retained (<6 months of orders). Logistic regressions estimated the odds of retention on buprenorphine by 1) patient characteristics and 2) timing of patient's engagement in buprenorphine treatment (pre- or post-implementation of an integrated treatment model). RESULTS: Of the study sample, 53% had ≥6 months of buprenorphine orders. Almost two times higher odds of retention were found among patients with ≥1 psychiatric comorbidity (versus none) and among those with buprenorphine orders in the post- versus pre-period. CONCLUSIONS: An integrated, interdisciplinary model of OUD treatment was associated with ≥6 months of buprenorphine orders among our study population. Continued research is needed in real-world primary care settings to understand the impact of OUD treatment models on patient outcomes. A more nuanced examination of the associations between psychiatric diagnoses and buprenorphine treatment retention is warranted.

Barriers and mechanisms of change: The impact of trauma and relationships.

In their article "Integrated Care Improves Mental Health in a Medically Underserved U.S. Mexico Border Population," Flynn, Gonzalez, Mata, Salinas, and Atkins (see record 2020-40858-002) report on an integrated care model using promotoras to address diabetes in a Latino population. Overall, they found that participants had improved quality of life (QoL) and depression measures; however, physical health outcomes did not improve significantly compared to the comparison group. In this commentary, we draw on our expertise working with the Latino population in mental health settings, most recently with refugees at the U.S.-Mexico border, as well as our experience working on integrated care teams and our deep understanding of the impact of trauma on health. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Predictors of Medication-Assisted Treatment Initiation for Opioid Use Disorder in an Interdisciplinary Primary Care Model.

INTRODUCTION: Medication-assisted treatment (MAT) for opioid use disorder (OUD) is underused in primary care. Little is known about patient demographics associated with MAT initiation, particularly among models with an interdisciplinary approach, including behavioral health integration. We hypothesize few disparities in MAT initiation by patient characteristics after implementing this model for OUD. METHODS: Electronic health record data were used to identify adults with ≥1 primary care visit in 1 of 2 study clinics in a Pacific Northwest academic health system between September 1, 2015 and August 31, 2017 (n = 23,372). Rates of documented OUD diagnosis were calculated. Multivariate logistic regression estimated odds ratios of MAT initiation, defined as ≥1 electronic health record order for buprenorphine or naltrexone, by patient covariates. RESULTS: Seven percent of the study sample had an OUD diagnosis. Of those patients, 32% had ≥1 MAT order. Patients with documented psychiatric diagnoses or tobacco use had higher odds of initiating MAT (odds ratio [OR] = 1.62, P = .0003; OR = 2.46, P < .0001, respectively). Uninsured, Medicaid, and Medicare patients had lower odds than those commercially insured (OR = 0.53, 0.38, and 0.31, respectively; P < .0001). Patients who were older, of a race/ethnicity other than non-Hispanic white, had documented diabetes, and had documented asthma or chronic obstructive pulmonary disease showed lower odds of initiation. DISCUSSION: MAT initiation varied by patient characteristics, including disparities by insurance coverage and race/ethnicity. The addition of behavioral health did not eliminate disparities in care, but higher odds of initiation among those with a documented psychiatric diagnosis may suggest this model reaches some vulnerable populations. Additional research is needed to further examine these findings.

Personal characteristics associated with the effect of childhood trauma on health.

Objective This article will describe a pilot study to explore associations between adult attachment style, resilience, Adverse Childhood Experiences, and adult health. Method A self-report survey was mailed to 180 randomly selected primary care patients and linked to a retrospective chart review. The patients met the following criteria: (1) enrolled for at least the previous year at their primary care clinic, (2) 21 years of age or greater, (3) English as their primary language, and (4) were seen by their provider on selected dates of the study. The survey was made up of three instruments: (1) the Adverse Childhood Experiences Questionnaire which consists of 10 questions about the respondent's adverse experiences during their first 18 years of life; (2) the Relationship Scales Questionnaire which measures adult attachment style; and (3) the Connor-Davidson Resilience Scale, a self-report scale that measures individual's perceptions of their resilience. For each returned questionnaire, we calculated a measure of medical complexity using the Elixhauser Comorbidity Index. Results Of the 180 randomly selected patients from four clinic sites, 84 (46.6%) returned completed questionnaires. We found that Adverse Childhood Experience scores were significantly correlated with health and attachment style and trended toward association with resilience. Conclusion This pilot study revealed expected relationships of the complex associations between Adverse Childhood Experiences, attachment style, and resiliency. Further research with more subjects is warranted in order to continue to explore these relationships.